Gadeta
is a Netherlands-based biopharmaceutical company that researches and develops TCR-based immunotherapies for the treatment of cancer... Read moreGadeta
is a Netherlands-based biopharmaceutical company that researches and develops TCR-based immunotherapies for the treatment of cancer... Read more
News
Oct 02, 2023
BioSpace
Gadeta: Clade Therapeutics Announces the Acquisition of Gadeta B.V.
Dec 05, 2022
Pharmabiz
Gadeta: Immunocore, Gadeta ink agreement to develop first gamma delta TCR ImmTAC for solid tumours
Dec 02, 2022
Endpoints News
Gadeta: In search for a 'universal T cell engager', Immunocore inks deal with Gilead-backed Gadeta
Oct 23, 2022
Best of Business Today
Gadeta: Gadeta Announces the Formation of a Scientific Advisory Board and a Status Report on the Company
Mar 28, 2022
PR Newswire
Press Release: Gadeta : Gadeta to Present Data on Tumor-Specific Cell Therapies at Leading Scientific Conferences
Mar 15, 2022
StreetInsider
Press Release: Gadeta : Gadeta announces significant progress in advancing pipeline and TEG platform development
Jul 06, 2021
Pharmafile
Gadeta: Novel cancer therapy kick starts clinical trials
Jul 06, 2021
Markets Insider
Gadeta: First Patient Dosed with Gadeta's gamma delta TCR Cell Therapy
Oct 01, 2018
BioPortfolio
Gadeta: Gadeta BV Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12092018 Prices from USD $250
Jul 25, 2018
Global University Venturing
Gadeta: Gadeta glides into Kite partnership
Gadeta Competitors
1
2
3
4
5
6
7
8
9
10